Baidu
map

心血管指南

订阅

MedSci主页 / 所有栏目 / 心血管指南

2019 KSC心脏康复指南：急性冠脉综合征后心脏康复和二级预防建议

2019-10-20 韩国心脏学会 Korean Circ J. 2019 Nov;49(11):1066-1111.

急性冠脉综合征心脏康复二级预防

2019年，韩国心脏学会(KSC)发布了急性冠脉综合征后心脏康复和二级预防建议指南，指南主要目的是针对急性冠脉综合征后心脏康复和二级预防提供最佳实践指导建议。内容涉及心脏康复的介绍、评估，锻炼治疗个二级预防的患者教育。

中文标题：

2019 KSC心脏康复指南：急性冠脉综合征后心脏康复和二级预防建议

英文标题：

Clinical Practice Guideline for Cardiac Rehabilitation in Korea: Recommendations for Cardiac Rehabilitation and Secondary Prevention after Acute Coronary Syndrome.

发布机构：

韩国心脏学会

发布日期：

2019-10-20

简要介绍：

2019年，韩国心脏学会(KSC)发布了急性冠脉综合征后心脏康复和二级预防建议指南，指南主要目的是针对急性冠脉综合征后心脏康复和二级预防提供最佳实践指导建议。内容涉及心脏康复的介绍、评估，锻炼治疗个二级预防的患者教育。

 

拓展指南：与急性冠脉综合征相关指南：

相关资料下载：
[AttachmentFileName(sort=100, fileName=2019 KSC心脏康复指南：急性冠脉综合征后心脏康复和二级预防建议)] GetToolGuiderByIdResponse(projectId=1, id=a1e7c1c001811ae5, title=2019 KSC心脏康复指南：急性冠脉综合征后心脏康复和二级预防建议, enTitle=Clinical Practice Guideline for Cardiac Rehabilitation in Korea: Recommendations for Cardiac Rehabilitation and Secondary Prevention after Acute Coronary Syndrome., guiderFrom=Korean Circ J. 2019 Nov;49(11):1066-1111., authorId=null, author=, summary=2019年，韩国心脏学会(KSC)发布了急性冠脉综合征后心脏康复和二级预防建议指南，指南主要目的是针对急性冠脉综合征后心脏康复和二级预防提供最佳实践指导建议。内容涉及心脏康复的介绍、评估，锻炼治疗个二级预防的患者教育。 , cover=, journalId=null, articlesId=null, associationId=1839, associationName=韩国心脏学会, associationIntro= , copyright=0, guiderPublishedTime=Sun Oct 20 00:00:00 CST 2019, originalUrl=, linkOutUrl=, content=<P>2019年，韩国心脏学会(KSC)发布了急性冠脉综合征后心脏康复和二级预防建议指南，指南主要目的是针对急性冠脉综合征后心脏康复和二级预防提供最佳实践指导建议。内容涉及心脏康复的介绍、评估，锻炼治疗个二级预防的患者教育。 </P> <P> </P>拓展指南：<STRONG>与<FONT color=red>急性冠脉综合征</FONT>相关指南：</STRONG><BR> <UL> <LI><A title="2019 EHRA共识：急性冠脉综合征和血运重建紧急情况下的心律失常" target=_blank href="//m.capotfarm.com/guideline/show_article.do?id=31a891c001e7562d">2019 EHRA共识：急性冠脉综合征和血运重建紧急情况下的心律失常</A> <LI><A title="2019 EAPCI专家共识：冠脉腔内影像学检查的临床应用-第2部分：急性冠脉综合征冠脉造影结果模糊患者介入治疗决策指导" target=_blank href="//m.capotfarm.com/guideline/show_article.do?id=fff041c001ea264b">2019 EAPCI专家共识：冠脉腔内影像学检查的临床应用-第2部分：急性冠脉综合征冠脉造影结果模糊患者介入治疗决策指导</A> <LI><A title=急性冠脉综合征急诊快速诊治指南（2019） target=_blank href="//m.capotfarm.com/guideline/show_article.do?id=40ed41c001e35370">急性冠脉综合征急诊快速诊治指南（2019）</A> <LI><A title="2018 JCS指南：急性冠脉综合征的诊断和治疗" target=_blank href="//m.capotfarm.com/guideline/show_article.do?id=f01cc1c001e290f8">2018 JCS指南：急性冠脉综合征的诊断和治疗</A> <LI><A title="2019 专家建议：延长亚洲急性冠脉综合征患者双抗治疗" target=_blank href="//m.capotfarm.com/guideline/show_article.do?id=a1be41c001e13236">2019 专家建议：延长亚洲急性冠脉综合征患者双抗治疗</A> 更多信息请点击：<A target=_blank href="//m.capotfarm.com/guideline/list.do?q=%E6%80%A5%E6%80%A7%E5%86%A0%E8%84%89%E7%BB%BC%E5%90%88%E5%BE%81">有关急性冠脉综合征更多指南</A></LI></UL>, tagList=[TagDto(tagId=360, tagName=急性冠脉综合征), TagDto(tagId=8725, tagName=心脏康复), TagDto(tagId=3552, tagName=二级预防)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=43, categoryName=冠心病, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=0, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=6979, appHits=401, showAppHits=8, pcHits=4232, showPcHits=3310, likes=64, shares=17, comments=9, approvalStatus=1, publishedTime=Wed Oct 30 00:49:38 CST 2019, publishedTimeString=2019-10-20, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Wed Oct 30 00:49:38 CST 2019, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 22:20:27 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2019 KSC心脏康复指南：急性冠脉综合征后心脏康复和二级预防建议)])
2019 KSC心脏康复指南：急性冠脉综合征后心脏康复和二级预防建议
下载请点击：
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1083021, encodeId=0db710830217a, content=下起来 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=12cb5438026, createdName=ms4000000901131801, createdTime=Wed Dec 22 11:07:41 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973752, encodeId=7d2a9e37522f, content=这个太好了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4b04838477, createdName=156699595, createdTime=Tue Jun 15 15:54:40 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=921199, encodeId=b739921199ba, content=学习！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0305457108, createdName=ms5000000270253628, createdTime=Fri Jan 29 20:55:10 CST 2021, time=2021-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897296, encodeId=70a989e29614, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211129/0708c577736746af9505e240c95bfe21/ed50f4e6812646388b702de78e18d26b.jpg, createdBy=e07e5430262, createdName=ms6000000490309621, createdTime=Fri Nov 06 12:01:39 CST 2020, time=2020-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897295, encodeId=fb4f89e295aa, content=棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211129/0708c577736746af9505e240c95bfe21/ed50f4e6812646388b702de78e18d26b.jpg, createdBy=e07e5430262, createdName=ms6000000490309621, createdTime=Fri Nov 06 12:01:33 CST 2020, time=2020-11-06, status=1, ipAttribution=)]
    2021-12-22 ms4000000901131801

    下起来

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1083021, encodeId=0db710830217a, content=下起来 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=12cb5438026, createdName=ms4000000901131801, createdTime=Wed Dec 22 11:07:41 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973752, encodeId=7d2a9e37522f, content=这个太好了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4b04838477, createdName=156699595, createdTime=Tue Jun 15 15:54:40 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=921199, encodeId=b739921199ba, content=学习！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0305457108, createdName=ms5000000270253628, createdTime=Fri Jan 29 20:55:10 CST 2021, time=2021-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897296, encodeId=70a989e29614, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211129/0708c577736746af9505e240c95bfe21/ed50f4e6812646388b702de78e18d26b.jpg, createdBy=e07e5430262, createdName=ms6000000490309621, createdTime=Fri Nov 06 12:01:39 CST 2020, time=2020-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897295, encodeId=fb4f89e295aa, content=棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211129/0708c577736746af9505e240c95bfe21/ed50f4e6812646388b702de78e18d26b.jpg, createdBy=e07e5430262, createdName=ms6000000490309621, createdTime=Fri Nov 06 12:01:33 CST 2020, time=2020-11-06, status=1, ipAttribution=)]
    2021-06-15 156699595

    这个太好了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1083021, encodeId=0db710830217a, content=下起来 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=12cb5438026, createdName=ms4000000901131801, createdTime=Wed Dec 22 11:07:41 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973752, encodeId=7d2a9e37522f, content=这个太好了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4b04838477, createdName=156699595, createdTime=Tue Jun 15 15:54:40 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=921199, encodeId=b739921199ba, content=学习！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0305457108, createdName=ms5000000270253628, createdTime=Fri Jan 29 20:55:10 CST 2021, time=2021-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897296, encodeId=70a989e29614, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211129/0708c577736746af9505e240c95bfe21/ed50f4e6812646388b702de78e18d26b.jpg, createdBy=e07e5430262, createdName=ms6000000490309621, createdTime=Fri Nov 06 12:01:39 CST 2020, time=2020-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897295, encodeId=fb4f89e295aa, content=棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211129/0708c577736746af9505e240c95bfe21/ed50f4e6812646388b702de78e18d26b.jpg, createdBy=e07e5430262, createdName=ms6000000490309621, createdTime=Fri Nov 06 12:01:33 CST 2020, time=2020-11-06, status=1, ipAttribution=)]
    2021-01-29 ms5000000270253628

    学习！

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1083021, encodeId=0db710830217a, content=下起来 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=12cb5438026, createdName=ms4000000901131801, createdTime=Wed Dec 22 11:07:41 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973752, encodeId=7d2a9e37522f, content=这个太好了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4b04838477, createdName=156699595, createdTime=Tue Jun 15 15:54:40 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=921199, encodeId=b739921199ba, content=学习！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0305457108, createdName=ms5000000270253628, createdTime=Fri Jan 29 20:55:10 CST 2021, time=2021-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897296, encodeId=70a989e29614, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211129/0708c577736746af9505e240c95bfe21/ed50f4e6812646388b702de78e18d26b.jpg, createdBy=e07e5430262, createdName=ms6000000490309621, createdTime=Fri Nov 06 12:01:39 CST 2020, time=2020-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897295, encodeId=fb4f89e295aa, content=棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211129/0708c577736746af9505e240c95bfe21/ed50f4e6812646388b702de78e18d26b.jpg, createdBy=e07e5430262, createdName=ms6000000490309621, createdTime=Fri Nov 06 12:01:33 CST 2020, time=2020-11-06, status=1, ipAttribution=)]
    2020-11-06 ms6000000490309621

    学习了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1083021, encodeId=0db710830217a, content=下起来 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=12cb5438026, createdName=ms4000000901131801, createdTime=Wed Dec 22 11:07:41 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973752, encodeId=7d2a9e37522f, content=这个太好了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4b04838477, createdName=156699595, createdTime=Tue Jun 15 15:54:40 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=921199, encodeId=b739921199ba, content=学习！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0305457108, createdName=ms5000000270253628, createdTime=Fri Jan 29 20:55:10 CST 2021, time=2021-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897296, encodeId=70a989e29614, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211129/0708c577736746af9505e240c95bfe21/ed50f4e6812646388b702de78e18d26b.jpg, createdBy=e07e5430262, createdName=ms6000000490309621, createdTime=Fri Nov 06 12:01:39 CST 2020, time=2020-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897295, encodeId=fb4f89e295aa, content=棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211129/0708c577736746af9505e240c95bfe21/ed50f4e6812646388b702de78e18d26b.jpg, createdBy=e07e5430262, createdName=ms6000000490309621, createdTime=Fri Nov 06 12:01:33 CST 2020, time=2020-11-06, status=1, ipAttribution=)]
    2020-11-06 ms6000000490309621

    棒

    0

相关指南

2019 EHRA共识：急性冠脉综合征和血运重建紧急情况下的心律失常

欧洲心律学会(EHRA,European Heart Rhythm Association) · 2019-07-29

急性冠脉综合征急诊快速诊治指南（2019）

中国医师协会急诊医师分会(CHINESE COLLEGE OF EMERGENCY PHYSICANS,CCEP) · 2019-04-20

2018 JCS指南：急性冠脉综合征的诊断和治疗

日本循环学会(JCS,Japanese Circulation Society) · 2019-03-29

2019 专家建议：延长亚洲急性冠脉综合征患者双抗治疗

亚洲心血管专家小组（统称） · 2019-03-01

2018 欧洲联合共识声明：房颤患者表现为急性冠脉综合征和/或经皮心血管介入治疗的抗栓治疗管理

欧洲心律学会(EHRA,European Heart Rhythm Association) · 2018-07-21

血小板功能检测在急性冠脉综合征患者抗血小板治疗中的应用专家共识

世界华人检验与病理医师协会 · 2018-06-12

Baidu
map
Baidu
map
Baidu
map